Registry of Lobbyists

Registration - Consultant

Abbott Laboratories Ltd. / John Laskin, Consultant

Registration Information

Client name: Abbott Laboratories Ltd.
Lobbyist name: John Laskin, Consultant
Initial registration start date: 2006-10-05
Registration status: Inactive
Registration Number: 781926-13891

Version 1 of 1 (2006-10-05 to 2007-03-30)

Version 1 of 1 (2006-10-05 to 2007-03-30) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.

A. Registrant

Consultant lobbyist name: John Laskin    Lobbyist business address
Consulting firm: Torys LLP
3000 -- 79 Wellington St. W.
Box 270, TD Centre
Toronto, ON  M5K 1N2
Canada
Position: Partner
Telephone number: 416-865-7317  
Fax number: 416-865-7380  
 
Former public office holder: No
Payment is contingent on the success of the undertaking: No

B. Information about Client

Client: Abbott Laboratories Ltd.
8401 Trans Canada Highway
St-Laurent, QC  H4S 1Z1
Canada
Telephone number: 514-832-7865
 
Client Representative: Caroline Jacques
 
Parent: The client is not a subsidiary of any other parent companies.
Coalition: The client is not a coalition.
Subsidiary: The client does not have any subsidiaries that could be affected by the outcome of the undertaking.
Individual, organization or corporation: The client's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
 
Was the client funded in whole or in part by any domestic or foreign government institution in the last completed financial year? No
 

C. Lobbying Activity Information

Federal departments or organizations which have been or will be communicated with during the course of the undertaking: Health Canada (HC), Industry Canada
Communication techniques that have been used or are expected to be used in the course of the undertaking:
Meetings, Telephone calls Written communications, whether in hard copy or electronic format
 
Subject Matter: Areas of Concern: Health, Industry, Intellectual Property
 

Details Regarding the Identified Subject Matter

Categories Description
Legislative Proposal Proposed amendments to the Patented Medicines (Notice of Compliance) Regulations




Date Modified: